Group 1 - NewLake Capital Partners, Inc. is a leading provider of real estate capital to state-licensed cannabis operators, focusing on sale-leaseback transactions and funding for build-to-suit projects [2] - The company owns a portfolio of 34 properties, which includes 15 cultivation facilities and 19 dispensaries, primarily leased to single tenants under triple-net lease agreements [2] - Anthony Coniglio, the President and CEO of NewLake, is scheduled to participate in a fireside chat on February 5, 2026, moderated by Pablo Zuanic [1]

Core Insights - Enlivex has implemented the world's first RAIN prediction markets token digital asset treasury strategy through RAIN token accumulation [1][3][7] - The company is focused on the clinical development of Allocetra, a novel therapy for knee osteoarthritis, addressing a significant unmet medical need in a growing market [2][8] Company Developments - Enlivex has closed a $212 million private investment, with plans to utilize the proceeds for the RAIN prediction markets token treasury strategy while maintaining its core business operations [3][7] - Former Italian Prime Minister Matteo Renzi has joined the Board of Directors, emphasizing the importance of responsible innovation and the potential of blockchain technologies [5] RAIN Protocol Overview - RAIN is a decentralized predictions and options protocol built on the Arbitrum network, allowing users to create and trade custom options on various markets [4] - The protocol features a deflationary Buyback & Burn mechanism and aims to be a leading platform for prediction markets, promoting transparency and community participation [4] Market Context - Osteoarthritis affects over 32.5 million Americans and more than 300 million people globally, with a projected increase to 78 million Americans by 2040 [8] - There are currently no FDA or EMA approved medications that can effectively halt or reverse the progression of joint damage in osteoarthritis patients, highlighting a critical need for effective treatments [8]

Core Viewpoint - The FUTR Corporation has engaged KCSA Strategic Communications to enhance its investor relations and capital markets strategy, aiming to attract US investors and promote its AI Agent App [1][2][3]. Group 1: Engagement with KCSA - KCSA will assist FUTR in engaging with current and potential investors and will develop a comprehensive capital markets strategy [2]. - The investor relations services will commence on October 15, 2025, for an initial term of six months, with a monthly fee of US$10,000 [3]. Group 2: Company Overview - The FUTR AI Agent App enables users to turn their data into everyday value by rewarding them for securely sharing their data, earning FUTR Tokens, and receiving personalized offers [5]. - Enterprises can also earn rewards for contributing consumer data, while brands utilize FUTR insights to personalize services and reduce acquisition costs [5]. Group 3: KCSA Strategic Communications - KCSA is an award-winning firm specializing in public relations, investor relations, and integrated marketing, with extensive experience in various industries [6].

Core Insights - Aduro Clean Technologies Inc. is actively participating in several investor and industry events in September 2025 to enhance its brand visibility and industry presence [1] - The company has initiated a public relations campaign with KCSA Strategic Communications to support its communication and marketing efforts [6][7] Event Participation - Aduro will present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025, providing access to institutional investors and industry leaders [2] - The company will also participate in the Gabelli Funds 3rd Annual PFAS Symposium on September 17, 2025, focusing on market opportunities related to environmental challenges [3] - Aduro is set to represent itself at the Nasdaq New York Climate Week Forum on September 23, 2025, discussing sustainable innovation and climate-focused investments [4] Public Relations Strategy - The KCSA Agreement includes expanded public relations services, such as media relations, ESG positioning, and amplification of technical and commercial milestones [7][8] - KCSA will deliver services across various platforms, including financial news outlets and social media, for a term of six months starting September 8, 2025, at a cost of US$10,000 per month [9]

Core Viewpoint - Micropolis Holding Co. is set to present at the Aegis Capital Corp. 2025 Virtual Conference, highlighting its advancements in unmanned ground vehicles and AI-driven security solutions [1]. Company Overview - Micropolis is a UAE-based company that specializes in the design, development, and manufacturing of unmanned ground vehicles (UGVs), AI systems, and smart infrastructure for urban, security, and industrial applications [3]. - The company possesses vertically integrated capabilities that encompass mechatronics, embedded systems, AI software, and high-level autonomy [3]. Presentation Details - The presentation is scheduled for May 20, 2025, at 12:30 p.m. ET [2]. - Interested parties can register for the webcast and obtain further information through Aegis Capital representatives or by contacting KCSA Strategic Communications [2].

Core Insights - Better Choice Company is participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, highlighting its commitment to the pet health and wellness sector [1][2] - SRx Health, a Canadian healthcare service provider, will present at the same conference, showcasing its focus on specialty pharmacy services [1][5] Company Overview - Better Choice Company is dedicated to transforming the pet health industry by offering nutrition-based products aimed at enhancing the health and longevity of pets [3] - The company primarily markets its products under the Halo brand, which emphasizes sustainably sourced ingredients and minimally processed diets [3] SRx Health Overview - SRx Health specializes in the Specialty Pharmacy segment, providing comprehensive healthcare services that include patient support programs and clinical trials [5][6] - The company aims to expand its specialty pharmacy locations from 34 to 100 across Canada, focusing on chronic and rare diseases [6]